Sachin P Mampatta, Sohini Das &Amp; Ruchika Chitravanshi

Stories by Sachin P Mampatta, Sohini Das &Amp; Ruchika Chitravanshi

'Bureaucrats Resist Meeting Public...'

'Bureaucrats Resist Meeting Public...'

Rediff.com   25 Aug 2025

'...as then it brings them closer to the complaints and grievances that the public faces.'

Stock exchanges freeze more promoter demat A/Cs for non-compliance

Stock exchanges freeze more promoter demat A/Cs for non-compliance

Rediff.com   21 Aug 2025

The number of companies with promoters whose demat accounts were frozen by the stock exchanges due to non-compliance increased over the past year. The BSE froze promoter demat accounts in 457 companies, according to data from the Securities and Exchange Board of India's (Sebi's) 2024-25 annual report released on August 12.

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

Rediff.com   12 Aug 2025

If pharmaceutical exports from India to the US come under a 25 per cent tariff bracket, the impact on earnings before interest, tax, depreciation and amortisation (Ebitda) could be around 5 per cent, felt analysts. This is after assuming that about 75 per cent of the tariff would be passed on.

US tariff impact: India's FY26 GDP growth likely to take 60-bp hit

US tariff impact: India's FY26 GDP growth likely to take 60-bp hit

Rediff.com   8 Aug 2025

The US' move to raise the tariff on most Indian goods to 50 per cent could drag India's GDP growth for FY26 by 35 to 60 basis points, according to various economists. One basis point (bp) is equal to 0.01 per cent.

Bihar Now Among Top 10 Investor States!

Bihar Now Among Top 10 Investor States!

Rediff.com   2 Aug 2025

Bihar is now among the top 10 states in terms of investor base, surging past better-off states like Delhi, Haryana, and Punjab.

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Rediff.com   31 Jul 2025

India's pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25 per cent tariff rate on India on a social networking platform without divulging the finer details.

P&G's New Boss Is Big Into Bollywood Movies

P&G's New Boss Is Big Into Bollywood Movies

Rediff.com   30 Jul 2025

Shailesh Jejurikar has 'always made an effort to stay close to his roots.'

There is more room for monetary policy easing, says Finance Ministry

There is more room for monetary policy easing, says Finance Ministry

Rediff.com   29 Jul 2025

With inflation comfortably below the Reserve Bank of India's (RBI's) 4 per cent median target and likely to undershoot its 3.7 per cent projection for 2025-26 (FY26), there is room for the monetary policy easing cycle to be sustained, the Finance Ministry said on Monday. The comments, featured in the ministry's Monthly Economic Review for June 2025, assume significance ahead of the Monetary Policy Committee (MPC) meeting of the Reserve Bank of India (RBI) scheduled to begin from August 5.

Tesla Hits Indian Roads But Misses Mass Appeal

Tesla Hits Indian Roads But Misses Mass Appeal

Rediff.com   29 Jul 2025

Analysts believe Tesla will first focus on building the Model Y brand before expanding -- both in terms of volume and models.

Govt to Monitor Non-Essential Drug Prices

Govt to Monitor Non-Essential Drug Prices

Rediff.com   28 Jul 2025

The National Pharmaceutical Pricing Authority will monitor how companies are increasing prices of non-scheduled drugs.

Coerced into signing documents: Sunjay Kapur's mother

Coerced into signing documents: Sunjay Kapur's mother

Rediff.com   26 Jul 2025

In her letter to the Sona BLW board, Rani Kapur said documents executed by her at a time of "mental and emotional vulnerability" were being misused.

BSE: Stock Exchange That Refused To Die

BSE: Stock Exchange That Refused To Die

Rediff.com   25 Jul 2025

The story of the Bombay Stock Exchange and the people who shaped its growth: From wars and bomb blasts to speculators, reformers and wealth creators.

Why NRIs are holding back on market bets

Why NRIs are holding back on market bets

Rediff.com   23 Jul 2025

Non-resident Indians (NRIs) haven't gone big on the Indian stock market story despite the post-pandemic boom. While domestic participation through mutual funds (MFs) and dematerialised accounts has soared, NRI participation figures show limited signs of a similar rise.

Manufacturing dominated new projects in Q1, share at 10-quarter high

Manufacturing dominated new projects in Q1, share at 10-quarter high

Rediff.com   21 Jul 2025

More than half of all new project announcements in the June 2025 quarter came from the manufacturing sector. Manufacturing projects worth around Rs 2.3 trillion were announced in the three-month period, accounting for 54 per cent of total new projects, according to data from the Centre for Monitoring Indian Economy (CMIE).

'People Ask Why You Have To Be So Rigid'

'People Ask Why You Have To Be So Rigid'

Rediff.com   17 Jul 2025

'It is not rigidity.' 'I am just sticking to what I believe very strongly in, particularly if you have been given an opportunity to serve the country....'

High equality ranking for India masks deeper gaps, say economists

High equality ranking for India masks deeper gaps, say economists

Rediff.com   14 Jul 2025

A recent World Bank report placing India among the most equal countries globally may present a limited view of inequality, with economists suggesting that broader data sets could tell a different story. According to the report, India's Gini index (or coefficient/ratio), a key measure of inequality, stood at 25.5 in 2022-23, placing the country fourth globally in terms of equality, behind only the Slovak Republic, Slovenia, and Belarus.

EV Sales Surge on Back of Government Push; Hybrids Lag

EV Sales Surge on Back of Government Push; Hybrids Lag

Rediff.com   8 Jul 2025

Despite the benefits of hybrid technology, a lack of government backing and few launches have kept the segment from gaining ground.

Breaking up bad assets: Can IBBI's part-resolution rewire insolvency rules?

Breaking up bad assets: Can IBBI's part-resolution rewire insolvency rules?

Rediff.com   7 Jul 2025

The recent notification by the Insolvency and Bankruptcy Board of India (IBBI) allowing part-resolution of stressed assets of companies under the insolvency process has sent many resolution professionals (RPs) and committees of creditors (CoCs) back to the drawing board to reassess their strategies for resolving corporate insolvencies.

Not pressing panic button on rare-earth supplies: Tata Motors

Not pressing panic button on rare-earth supplies: Tata Motors

Rediff.com   3 Jul 2025

'The reported deal between the European Union and China should mitigate it (shortage) for the medium to long term. Let's wait and watch how this plays out.'

Govt unveils Rs 2 trillion dose for jobs, R&D, innovation, growth push

Govt unveils Rs 2 trillion dose for jobs, R&D, innovation, growth push

Rediff.com   2 Jul 2025

In a double-dose bid to boost growth and employment prospects, the Union Cabinet on Tuesday approved a Rs 2.07 trillion outlay for a research development and innovation (RDI) Scheme to fund private sector innovations, and an employment-linked incentive (ELI) to create over 35 million new jobs over the next two years.